v3.26.1
Balance Sheet Components
3 Months Ended
Mar. 31, 2026
Balance Sheet Components  
Balance Sheet Components

5.       Balance Sheet Components

Intangible Assets, Net

Intangible assets, net consisted of the following:

  ​ ​ ​

March 31, 

December 31, 

(in thousands)

2026

  ​ ​ ​

2025

Finite-lived assets, net of accumulated amortization of $5,625 and $5,000 as of March 31, 2026 and December 31, 2025, respectively

$

19,375

$

20,000

Indefinite-lived assets - in-process research and development

26,239

26,239

Total Intangible assets, net

$

45,614

$

46,239

Amortization expense related to finite-lived intangible assets was $0.6 million and $0.7 million for the three months ended March 31, 2026 and 2025, respectively.

Accrued and Other Current Liabilities

Accrued and other current liabilities consisted of the following:

  ​ ​ ​

March 31, 

December 31, 

(in thousands)

2026

  ​ ​ ​

2025

Accrued commercial and research and development manufacturing

$

2,425

$

7,349

Lease liabilities, current

1,899

1,828

Accrued other

 

10,878

 

11,253

Total Accrued and other current liabilities

$

15,202

$

20,430

Other Liabilities, Non-current

Other liabilities, non-current consisted of the following:

  ​ ​ ​

March 31, 

December 31, 

(in thousands)

2026

  ​ ​ ​

2025

Deferred tax liability

$

1,102

$

1,102

Revenue participation liability, non-current (Note 8)

14,372

14,028

Royalty fee derivative liability, non-current (Note 3)

1,490

1,490

Other

2

1,815

Total Other liabilities, non-current

$

16,966

$

18,435